Archives

by in
Entry Author Date Location
ViaCyte CEO Says $10M Grant Will Move Stem Cell Therapy to Trial 10/30/12 San Diego
Shire Hunts More Deals Amid Reawakening Interest in Stem Cell R&D 10/29/12 San Diego
San Diego’s Cebix Names CEO, Raises $30.9M to Advance Diabetes Drug 10/17/12 San Diego
San Diego Life Sciences Roundup: Regulus, Aragon, Cytori, & More 10/05/12 San Diego
Kineta Pulls in $5.8M for Autoimmune Drug 08/14/12 Seattle
Novo Nordisk Weaves Itself Into Seattle Biotech, With Diabetes R&D 07/06/12 Seattle
San Diego Life Sciences News: AnaptysBio, Life, NeuroGenetic & More 01/12/12 San Diego
Cebix to Raise $20 Million for Pivotal Trial of Diabetes Supplement 01/10/12 San Diego
Helmsley Trust Funds New Boston-Based Website for Diabetes Patients 08/10/11 Boston
Tolerx and Glaxo Diabetes Drug Disappoints in Late-Stage Study 03/11/11 Boston
Lee Hartwell’s Next Career Move, Swedish’s Social Media Ace, Cell Therapeutics’ Lifeline, & More Seattle-Area Life Sciences News 09/23/10 Seattle
Glaxo’s Tempero Pharma Advances on Hot Niche of Immunology 07/15/10 Boston
Leroy Hood’s Personalized Medicine Vision Enters Proving Ground at Ohio State 05/18/10 Seattle
Kineta Nabs $600K NIH Grant 04/05/10 Seattle
Tolerx, After a Decade and $150M, Eagerly Awaits Data from Big Diabetes Trial 03/04/10 Boston
Kineta Acquires Multiple Sclerosis, Diabetes Drug Candidates to Test Unusual Biotech Strategy 07/08/09 Seattle
Biotech Neighbors, VLST and Novo Nordisk, Forge Alliance in Seattle’s South Lake Union 04/06/09 Seattle
Illumina Shows its Stuff to Wall Street, Stock Still Slides 11/07/08 San Diego
RI Turns To Innovation Economy in Face of Record Job Losses; A List of Tech and Life Sciences Firms in the State to Watch 11/06/08 Boston
Page 1 of 1

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Zillions of Biotech Conferences Want You. Which Should You Attend?
  4. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  5. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.